drugset / Trial / NCT02566564

Intra-articular Lopain (MTX-071) Phase I/IIa Study in Chronic Osteoarthritic Knee Joint Pain

NCT02566564

Phase 1 Completed 23 enrolled Grünenthal GmbH
NaSingle-groupOpen-labelSupportive care

Summary

Phase I/IIa study to determine the safety and clinical effects of intra-articular injections of MTX-071 (Lopain) in patients with chronic osteoarthritic knee-joint pain.

Timeline

Start
2016-04
Primary completion
2017-06
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Resiniferatoxin Other / unclassified Other

Indications